The Purpose of This Study is to Determine Whether Topical Application of PEP005 is Safe for the Treatment of Common Wart(s)
type: MedicalStudy
description: A Phase I, Single-Centre, Open-Label, Fixed-Dose Study of the Safety and Efficacy of up- to Three-Days Application of 0.05% PEP005 Topical Gel in the Treatment of Patients With Common Wart(s) (Verruca[e] Vulgaris) on the Dorsal Hand
status: WITHDRAWN
study design: INTERVENTIONAL
phase: PHASE1
start date: 2007-10
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00546611
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Peplin
study subject: Warts
keywords: PHASE1
keywords: INTERVENTIONAL
keywords: WITHDRAWN
keywords: Warts

AI Analytics
type: Organization